Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis
Vito A. G. Ricigliano(Inserm), Benedetta Bodini(Inserm), Michel Bottlaender(Centre National de la Recherche Scientifique), Émilie Poirion(Inserm), Élisabeth Maillart(Sorbonne Université), Mattéo Tonietto(Centre National de la Recherche Scientifique), Andrea Lazzarotto(Centre National de la Recherche Scientifique), Philippe Gervais(Centre National de la Recherche Scientifique), Mariem Hamzaoui(Inserm), Bruno Stankoff(Pitié-Salpêtrière Hospital)
Cited by 24
Related Papers
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Brain atrophy and lesion load predict long term disability in multiple sclerosis
|Journal of Neurology Neurosurgery & Psychiatry|2013|327
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293